Page last updated: 2024-08-21

isoxazoles and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

isoxazoles has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akahane, K; DeAngelo, DJ; Look, AT; Mansour, MR; Radimerski, T; Sanda, T; Weinstock, DM	1

Other Studies

1 other study(ies) available for isoxazoles and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Article	Year
HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia. Leukemia, 2016, Volume: 30, Issue:1 Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; bcl-Associated Death Protein; Cell Line, Tumor; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Membrane Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resorcinols; TYK2 Kinase	2016

Article

Year

HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia.

Leukemia, 2016, Volume: 30, Issue:1

Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; bcl-Associated Death Protein; Cell Line, Tumor; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Membrane Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resorcinols; TYK2 Kinase

2016